Bismuth(III) acetate, 99%, 25g

N-[3-[[5-Cyclopropyl-2-[[3-(4-morpholinylmethyl)phenyl]amino]-4-pyrimidinyl]amino]propyl]cyclobutanecarboxamide, 98%, 250mg

3-Hydroxybenzotrifluoride, 99.0%, 100g

3-(4-Methanesulfonyl-phenyl)-[1,2,4]oxadiazol-5-ol, 95.0%, 1g

6-Bromo-7-azaindole, 98.0%, 1g

2-Chloroethyl 5-(1,3-dioxolan-2-yl)-2-thienyl ketone, 97.0%, 1g

3-cyclopropyl-1-phenyl-1H-pyrazole-5-carboxylic acid, 95.0%, 500mg

5-Fluoro-2,4-dihydroxybenzaldehyde, 95%, 250mg

1,3-Butanediol Dimethacrylate (stabilized with MEHQ)>98.0%(GC)25mL

5-Hydroxy-4-methoxy-2-nitro-benzaldehyde, 95.0%, 1g

3-Bromo-1-methyl-5-phenyl-1H-pyrazole, 95%, 100mg

Colonna capillare per GC ROTI®Cap-5, 50 m, 0.20 mm, 0.20 µm, 1 Pezzo(i)

4-Nitrophenyl hydrogen phenylphosphonate, 95.0%, 1g